Lyvgen Is A Biopharmaceutical Company Focused On Developing Novel Therapies For Cancerlyvgen S Xlinkaba C Functional Platform Creates Agonist Antibodiesabswith Tumor Localized Immunostimulatory Activities By Balancing Multiplefunctions Of Candidateabslyvgen S Most Advanced Programs Includelvgn6051A Monoclonal Antibodymabagonist For Cd1 7 4 1Bblvgn7409A Mab Agonist For Cd40Lvgn167 A Bispecific Antibodybsabblocking Pd L1 And Trapping Tgfi 1 2 And Anti Pd 1 Blocking Antibody Lvgn 616Lyvgen Has Initiated Phasei Clinical Trial Of Lvgn6051 Aloneor In Combination With Anti Pd 1 Antibody In Theusalyvgen Plans To Start Phasei Testing Of Lvgn6051 In Chinalvgn7409 And Lvgn167 Globallylyvgen Employs Over 5 Scientists With Global Pharmaceutical Research And Development Experiences At Its Research Sites In China And Theusa
No conferences found for this company.
| Company Name | Lyvgen Biopharma Holdings Ltd |
| Country |
China
|
| Address | N/A |
| Telephone | N/A |
| N/A |
